Registration number:
Medeor Pharma Limited
for the Year Ended 30 September 2017
Medeor Pharma Limited
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Financial Statements |
Medeor Pharma Limited
Company Information
Director |
Dr D J Tapolczay |
Registered office |
|
Bankers |
|
Accountants |
|
Page 1 |
Medeor Pharma Limited
(Registration number: 05938602)
Balance Sheet as at 30 September 2017
Note |
2017 |
(As restated) |
|
Fixed assets |
- |
|
|
Current assets |
|
|
|
Creditors: Amounts falling due within one year |
( |
( |
|
Net current liabilities |
( |
( |
|
Total assets less current liabilities |
( |
( |
|
Accruals and deferred income |
( |
( |
|
( |
( |
||
Capital and reserves |
( |
( |
Page 2 |
Medeor Pharma Limited
(Registration number: 05938602)
Balance Sheet as at 30 September 2017
Notes to the Financial Statements for the Year Ended 30 September 2017
General information |
The company is a private company limited by share capital incorporated in England and Wales.
The address of its registered office is:
The principal place of business is:
32 Crouch Hall Lane
Redbourn
St Albans
Hertfordshire AL3 7EU
These financial statements were authorised for issue by the
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.
Related party transactions |
Transactions with directors |
2017 |
At 1 October 2016 |
At 30 September 2017 |
Dr D J Tapolczay |
||
Loan from Director |
20,000 |
|
2016 |
At 1 October 2015 |
At 30 September 2016 |
Dr D J Tapolczay |
||
Loan from Director |
20,000 |
|
Page 3 |
Medeor Pharma Limited
(Registration number: 05938602)
Balance Sheet as at 30 September 2017
These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
For the financial year ending 30 September 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
• |
|
• |
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
Approved and authorised by the
.........................................
Dr D J Tapolczay
Director
Page 4 |